Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective
- 12 October 2017
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 139 (42), 14817-14824
- https://doi.org/10.1021/jacs.7b07807
Abstract
A significant challenge toward studies of the human microbiota involves establishing causal links between bacterial metabolites and human health and disease states. Certain strains of commensal Escherichia coli harbor the 54-kb clb gene cluster which codes for small molecules named precolibactins and colibactins. Several studies suggest colibactins are genotoxins and support a role for clb metabolites in colorectal cancer formation. Significant advances toward elucidating the structures and biosynthesis of the precolibactins and colibactins have been made using genetic approaches, but their full structures remain unknown. In this Perspective we describe recent synthetic efforts that have leveraged biosynthetic advances and shed light on the mechanism of action of clb metabolites. These studies indicate that deletion of the colibactin peptidase ClbP, a modification introduced to promote accumulation of precolibactins, leads to the production of non-genotoxic pyridone-based isolates derived from the diversion of linear biosynthetic intermediates toward alternative cyclization pathways. Furthermore, these studies suggest the active genotoxins (colibactins) are unsaturated imines that are potent DNA damaging agents, thereby confirming an earlier mechanism of action hypothesis. Although these imines have very recently been detected in bacterial extracts, they have to date confounded isolation. As the power of "meta-omics" approaches to natural products discovery further advance, we anticipate that chemical synthetic and biosynthetic studies will become increasingly interdependent.Keywords
Funding Information
- Yale University
- National Institute of General Medical Sciences (GM110506)
This publication has 44 references indexed in Scilit:
- Locoregional Effects of Microbiota in a Preclinical Model of Colon CarcinogenesisCancer Research, 2017
- The Enterobacterial Genotoxins: Cytolethal Distending Toxin and ColibactinEcoSal Plus, 2016
- Linking Biosynthetic Gene Clusters to their Metabolites via Pathway- Targeted Molecular NetworkingCurrent Topics in Medicinal Chemistry, 2016
- Colibactin: understanding an elusive gut bacterial genotoxinNatural Product Reports, 2015
- The Microbes inside Us and the Race for ColibactinAngewandte Chemie, 2015
- Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotypeGut, 2014
- Colonization of the Human Gut by E. coli and Colorectal Cancer RiskClinical Cancer Research, 2014
- High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon CancerPLOS ONE, 2013
- Intestinal Inflammation Targets Cancer-Inducing Activity of the MicrobiotaScience, 2012
- MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasisNature Medicine, 2008